Skip to main navigation Skip to search Skip to main content

Extended pulsated drug release from PLGA-based minirods

  • Y. Danyuo
  • , O. E. Oberaifo
  • , J. D. Obayemi
  • , S. Dozie-Nwachukwu
  • , C. J. Ani
  • , O. S. Odusanya
  • , M. G. Zebaze Kana
  • , K. Malatesta
  • , W. O. Soboyejo

Research output: Contribution to journalArticlepeer-review

6 Scopus citations

Abstract

The kinetics of degradation and sustained cancer drugs (paclitaxel (PT) and prodigiosin (PG)) release are presented for minirods (each with diameter of ~5 and ~6 mm thick). Drug release and degradation mechanisms were studied from solvent-casted cancer drug-based minirods under in vitro conditions in phosphate buffer solution (PBS) at a pH of 7.4. The immersed minirods were mechanically agitated at 60 revolutions per minute (rpm) under incubation at 37 °C throughout the period of the study. The kinetics of drug release was studied using ultraviolet visible spectrometry (UV-Vis). This was used to determine the amount of drug released at 535 nm for poly(lactic-co-glycolic acid) loaded with prodigiosin (PLGA-PG) samples, and at 210 nm, for paclitaxel-loaded samples (PLGA-PT). The degradation characteristics of PLGA-PG and PLGA-PT are elucidated using optical microscope as well as scanning electron microscope (SEM). Statistical analysis of drug release and degradation mechanisms of PLGA-based minirods were performed. The implications of the results are discussed for potential applications in implantable/degradable structures for multi-pulse cancer drug delivery.

Original languageEnglish
Article number61
JournalJournal of Materials Science: Materials in Medicine
Volume28
Issue number4
DOIs
StatePublished - Apr 1 2017

Fingerprint

Dive into the research topics of 'Extended pulsated drug release from PLGA-based minirods'. Together they form a unique fingerprint.

Cite this